Catalyst Wire Dossier Catalyst Wire Dossier

Rohto Hydra

· ORA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rohto Hydra, covering 2018-12-19 to 2018-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra) [Phase 4]

See pricing